找回密码
 To register

QQ登录

只需一步,快速开始

扫一扫,访问微社区

Titlebook: Difficult Decisions in Cardiothoracic Critical Care Surgery; An Evidence-Based Ap Vassyl A. Lonchyna Book 2019 Springer Nature Switzerland

[复制链接]
楼主: graphic
发表于 2025-3-30 08:25:08 | 显示全部楼层
发表于 2025-3-30 12:46:52 | 显示全部楼层
发表于 2025-3-30 16:40:50 | 显示全部楼层
发表于 2025-3-30 22:31:49 | 显示全部楼层
Grundlagen des RisikoregulierungsrechtsThe authors were tasked with developing their chapter themes by structuring the questions to be asked according to the PICO (Patients of interest, the Intervention that was applied, Comparator patients with similar conditions but treated differently, and Outcomes of interest) model.
发表于 2025-3-31 02:58:04 | 显示全部楼层
发表于 2025-3-31 06:12:30 | 显示全部楼层
Recht und Tabu — ein Problemaufrißat the bedside by a non-cardiologist to evaluate for a defined list of diagnoses. Several subspecialties have shown the value of using FCU in conjunction with physical exam and monitoring devices to guide patient assessment and management. This chapter will address the use of FCU in critically ill patients, with a focus on the CTICU.
发表于 2025-3-31 11:30:39 | 显示全部楼层
Verbotene Bäume im Garten der Freiheit In catecholamine resistant shock, vasopressin may be utilized. In severe, life-threatening shock, methylene blue has shown efficacy in improving hemodynamics and decreasing need for vasoconstrictors.
发表于 2025-3-31 17:06:11 | 显示全部楼层
https://doi.org/10.1007/978-3-662-59746-0 venoarterial ECMO should be considered the first-line of intervention in the non-sternotomy patient suffering refractory cardiac arrest. If resuscitation via ECMO is not available, a sternotomy is an acceptable alternative as long as the operating surgeon is available or a trained team is comfortable with performing a fresh sternotomy.
发表于 2025-3-31 17:43:27 | 显示全部楼层
发表于 2025-3-31 23:22:52 | 显示全部楼层
Organisation der Planungsbeteiligtenirect current (DC) cardioversion used as necessary in high-risk patients who develop POAF. Numerous other medications and modalities, such as biatrial pacing, have been used for POAF prophylaxis and treatment with limited success.
 关于派博传思  派博传思旗下网站  友情链接
派博传思介绍 公司地理位置 论文服务流程 影响因子官网 SITEMAP 大讲堂 北京大学 Oxford Uni. Harvard Uni.
发展历史沿革 期刊点评 投稿经验总结 SCIENCEGARD IMPACTFACTOR 派博系数 清华大学 Yale Uni. Stanford Uni.
|Archiver|手机版|小黑屋| 派博传思国际 ( 京公网安备110108008328) GMT+8, 2025-6-28 03:24
Copyright © 2001-2015 派博传思   京公网安备110108008328 版权所有 All rights reserved
快速回复 返回顶部 返回列表